.jpg)
.png)
First off, I would like to wish you all well and offer you a warm e-embrace on behalf of the LipidSpin team. I would also like to apologize for the delay in releasing this issue featuring the SWLA; we’ve been a bit distracted by a global health crisis and our schedule got pushed back.
Article By:
Editor, LipidSpin
Clinical Associate Professor of Medicine
University of Pennsylvania
Internal Medicine and Preventive Cardiology
University of Pennsylvania Health System
Philadelphia, PA
Diplomate, American Board of Clinical Lipidology
It is my privilege to proudly present this edition of LipidSpin from the Southwest Chapter of the National Lipid Association (SWLA). This chapter includes the states of Arizona, Colorado, New Mexico, Texas, Louisiana, Oklahoma, and Wyoming. This edition will address some new topics not covered before, as well as reinforce current ideas considered mainstream by lipid specialists nationwide. I am also pleased to share a very important article by my good friend, Dr.
Article By:
President, Southwest Lipid Association (2019-2020)
Associate Professor Family Medicine Midwestern University
Glendale, AZ
Private Practice
Scottsdale, AZ
Diplomate, American Board of Clinical Lipidology
The Winner is...Trevor Hadley, BS!
The National Lipid Association (NLA) and the Foundation of the NLA are proud to announce the winner of the 2020 Young Investigator Award for outstanding lipid research: Trevor D. Hadley, BS, Baylor College of Medicine, Houston, Texas, for abstract 213 titled:
Genetic Testing for Hypertriglyceridemia--Experience from a single center lipid clinic
Congratulations to Aleesha Shaik, MD, New York, NY, for winning second-place
Denver-area clinical pharmacist assumes role during NLA virtual business meeting
JACKSONVILLE, Fla. — Joseph J. Saseen, PharmD, CLS, FNLA, officially assumed the role of National Lipid Association (NLA) President at the NLA’s annual virtual business meeting on Monday, June 8, 2020 after serving for the past year as President-Elect. He succeeds Houston-based lipidologist Antonio M. Gotto, MD, DPhil, FNLA, who will be the NLA’s Immediate Past President.
Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.
|
Register for the NLA Annual Business Meeting by clicking here.
Join us on Monday, June 8 from 6:00 – 6:30 PM ET for the NLA’s Annual Business Meeting for important NLA updates and award announcements:
View the April 2020 Midwest quarterly e-newsletter by clicking here.
View the April 2020 Pacific quarterly e-newsletter by clicking here.